ArticleThe Journal of experimental medicine2022

Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma.

Yu Rebecca Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.